Search

Michael D. Burkhart

Examiner (ID: 9343, Phone: (571)272-2915 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1633, 1638, 1636
Total Applications
1159
Issued Applications
604
Pending Applications
127
Abandoned Applications
447

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8814194 [patent_doc_number] => 20130115239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'PROSTATE CANCER DNA VACCINE' [patent_app_type] => utility [patent_app_number] => 13/513531 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6460 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513531 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/513531
PROSTATE CANCER DNA VACCINE Nov 24, 2010 Abandoned
Array ( [id] => 6000851 [patent_doc_number] => 20110117169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR CAPTURE OF CELLS' [patent_app_type] => utility [patent_app_number] => 12/949767 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21793 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117169.pdf [firstpage_image] =>[orig_patent_app_number] => 12949767 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/949767
METHODS AND COMPOSITIONS FOR CAPTURE OF CELLS Nov 17, 2010 Abandoned
Array ( [id] => 8503329 [patent_doc_number] => 20120302738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Recombinant antibody vector' [patent_app_type] => utility [patent_app_number] => 13/510269 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7530 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510269 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/510269
Recombinant antibody vector Nov 15, 2010 Abandoned
Array ( [id] => 5969008 [patent_doc_number] => 20110150861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SORF CONSTRUCTS AND MULTIPLE GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/914556 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 35096 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150861.pdf [firstpage_image] =>[orig_patent_app_number] => 12914556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/914556
SORF CONSTRUCTS AND MULTIPLE GENE EXPRESSION Oct 27, 2010 Abandoned
Array ( [id] => 6055814 [patent_doc_number] => 20110112174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PEPTIDE BIOSYNTHESIS AND PAIN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/893255 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9736 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112174.pdf [firstpage_image] =>[orig_patent_app_number] => 12893255 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/893255
Peptide biosynthesis and pain therapy Sep 28, 2010 Issued
Array ( [id] => 9762563 [patent_doc_number] => 08846889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Peptide biosynthesis and pain therapy' [patent_app_type] => utility [patent_app_number] => 12/893352 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9744 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12893352 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/893352
Peptide biosynthesis and pain therapy Sep 28, 2010 Issued
Array ( [id] => 6096404 [patent_doc_number] => 20110003381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'VIRAL VECTORS AND HOST CELLS AND METHODS OF MAKING AND USING THEM' [patent_app_type] => utility [patent_app_number] => 12/883126 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23837 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003381.pdf [firstpage_image] =>[orig_patent_app_number] => 12883126 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/883126
VIRAL VECTORS AND HOST CELLS AND METHODS OF MAKING AND USING THEM Sep 14, 2010 Abandoned
Array ( [id] => 5978289 [patent_doc_number] => 20110071212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'P185NEU-ENCODING DNA AND THERAPEUTICAL USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/874619 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6168 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071212.pdf [firstpage_image] =>[orig_patent_app_number] => 12874619 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/874619
p185neu-encoding DNA and therapeutical uses thereof Sep 1, 2010 Issued
Array ( [id] => 6070633 [patent_doc_number] => 20110045483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Diagnostic Screens for Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 12/870987 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16394 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045483.pdf [firstpage_image] =>[orig_patent_app_number] => 12870987 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/870987
Diagnostic screens for Alzheimer's disease Aug 29, 2010 Issued
Array ( [id] => 8968837 [patent_doc_number] => 08507648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Detection of truncation mutations by mass spectrometry' [patent_app_type] => utility [patent_app_number] => 12/850499 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 39 [patent_no_of_words] => 28435 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12850499 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/850499
Detection of truncation mutations by mass spectrometry Aug 3, 2010 Issued
Array ( [id] => 6111296 [patent_doc_number] => 20110189716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHOD FOR ANALYZING COLLAGENOUS TISSUES FOR THE DETECTION AND DIAGNOSIS OF BONE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/847408 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19460 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189716.pdf [firstpage_image] =>[orig_patent_app_number] => 12847408 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/847408
Method for analyzing collagenous tissues for the detection and diagnosis of bone disease Jul 29, 2010 Issued
Array ( [id] => 6623685 [patent_doc_number] => 20100311160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom' [patent_app_type] => utility [patent_app_number] => 12/804687 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11012 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311160.pdf [firstpage_image] =>[orig_patent_app_number] => 12804687 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/804687
Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom Jul 25, 2010 Issued
Array ( [id] => 8759870 [patent_doc_number] => 08420389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Nipah virus vaccines' [patent_app_type] => utility [patent_app_number] => 12/839556 [patent_app_country] => US [patent_app_date] => 2010-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 19 [patent_no_of_words] => 15488 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12839556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/839556
Nipah virus vaccines Jul 19, 2010 Issued
Array ( [id] => 6081806 [patent_doc_number] => 20110143440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Mutations caused by activation-induced cytidine deaminase' [patent_app_type] => utility [patent_app_number] => 12/804089 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17811 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143440.pdf [firstpage_image] =>[orig_patent_app_number] => 12804089 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/804089
Mutations caused by activation-induced cytidine deaminase Jul 12, 2010 Abandoned
Array ( [id] => 6024365 [patent_doc_number] => 20110052691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Sustained Release Systems and Preparation Method Thereof' [patent_app_type] => utility [patent_app_number] => 12/832248 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3889 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052691.pdf [firstpage_image] =>[orig_patent_app_number] => 12832248 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/832248
Sustained release systems and preparation method thereof Jul 7, 2010 Issued
Array ( [id] => 5968974 [patent_doc_number] => 20110150840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Detection and Treatment of Glyco-Enzyme-Related Disease' [patent_app_type] => utility [patent_app_number] => 12/793539 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 25085 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150840.pdf [firstpage_image] =>[orig_patent_app_number] => 12793539 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/793539
Detection and Treatment of Glyco-Enzyme-Related Disease Jun 2, 2010 Abandoned
Array ( [id] => 7817984 [patent_doc_number] => 20120064604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHODS FOR ENHANCING INFECTIVITY OF RETROVIRUSES' [patent_app_type] => utility [patent_app_number] => 13/321509 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15575 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064604.pdf [firstpage_image] =>[orig_patent_app_number] => 13321509 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/321509
Methods for enhancing infectivity of retroviruses May 17, 2010 Issued
Array ( [id] => 5944053 [patent_doc_number] => 20110104673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY' [patent_app_type] => utility [patent_app_number] => 12/755236 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6708 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104673.pdf [firstpage_image] =>[orig_patent_app_number] => 12755236 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/755236
NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY Apr 5, 2010 Abandoned
Array ( [id] => 7489925 [patent_doc_number] => 20110237447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHOD OF DETERMINING CHROMATIN STRUCTURE' [patent_app_type] => utility [patent_app_number] => 12/754038 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26249 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237447.pdf [firstpage_image] =>[orig_patent_app_number] => 12754038 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/754038
METHOD OF DETERMINING CHROMATIN STRUCTURE Apr 4, 2010 Abandoned
Array ( [id] => 6453948 [patent_doc_number] => 20100189684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY' [patent_app_type] => utility [patent_app_number] => 12/754335 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189684.pdf [firstpage_image] =>[orig_patent_app_number] => 12754335 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/754335
Use of gp130 activators in diabetic neuropathy Apr 4, 2010 Issued
Menu